Effect of Calcium 500 mg and Vitamin D3 1000 IU Chewable Tablet on Intestinal Calcium Absorption
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that the intestinal absorption of calcium from a
novel calcium carbonate-vitamin D3 chewable tablet formulation (calcium 500 milligrams (mg)
and vitamin D3 1000 International Units (IU)) increases the amount of calcium excreted in
urine and decreases parathyroid hormone (PTH) in serum as compared with Baseline.
Phase:
Phase 1
Details
Lead Sponsor:
Takeda
Treatments:
Calcium Carbonate Calcium, Dietary Cholecalciferol Ergocalciferols Vitamin D Vitamins